| 12071423 |
Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-N-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide hemisuccinate, and preparation of 2,4,6-trifluoro-N-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide acetate |
Aktham Aburub, David Coates, Mark Steven Kerr, Roger Ryan Rothhaar, Radhe Krishan Vaid |
2024-08-27 |
| 11827618 |
Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-n-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide hemisuccinate, and preparation of 2,4,6-trifluoro-n-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide acetate |
Aktham Aburub, David Coates, Mark Steven Kerr, Roger Ryan Rothhaar, Radhe Krishan Vaid |
2023-11-28 |
| 8299060 |
Trans-4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl] (2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid |
Xinchao Chen, Steven Wayne Pedersen, David Michael Remick |
2012-10-30 |
| 8217032 |
Selective estrogen receptor modulators for the treatment of vasomotor symptoms |
Robert Dally, Jeffrey A. Dodge, Ronald Jay Hinklin, Timothy Alan Shepherd, Owen Brendan Wallace |
2012-07-10 |
| 7585977 |
Selective estrogen receptor modulators containing a phenylsulfonyl group |
Robert Dally, Jeffrey A. Dodge, Scott Alan Jones, Timothy Alan Shepherd, Owen Brendan Wallace +3 more |
2009-09-08 |
| 5434171 |
Preparation of 3,4,4-trisubstituted-piperidinyl-N-alkylcarboxylates and intermediates |
Douglas E. Prather, Jeffrey A. Ward, John A. Werner |
1995-07-18 |